Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-08-23Clinical Trial Update: Effect of Transcutaneous Electrical Nerve Stimulation on Cognition in Multiple Sclerosis Patients [NA]
This clinical trial update examines whether transcutaneous electrical nerve stimulation affects cognition in patients with multiple sclerosi…
-
CLINICAL_TRIALS trial_result · 2016-08-15Clinical Trial Update: Locomotor Training in Persons With Multiple Sclerosis [Phase 1, Phase 2]
This clinical trial update reports Phase 1 and Phase 2 results for locomotor training in people with multiple sclerosis, with the results po…
-
CLINICAL_TRIALS trial_result · 2016-08-12Clinical Trial Update: Telehealth-Based Exercise Program to Treat Fatigue in MS [NA]
A completed clinical trial evaluated a telehealth-based exercise program to treat fatigue in multiple sclerosis.
-
CLINICAL_TRIALS withdrawal · 2016-08-11Clinical Trial Update: Phase 3, 28-week, Randomized, Double-blind, Placebo-controlled Safety and Efficacy Study of Nabiximols as an add-on Therapy in Subjects With Spasticity Due to Multiple Sclerosis. [Phase 3]
A Phase 3 randomized, double-blind, placebo-controlled study evaluating nabiximols as add-on therapy for spasticity in multiple sclerosis ha…
-
CLINICAL_TRIALS research · 2016-08-09Clinical Trial Update: Multimodel Magnetic Resonance Imaging (MRI)of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
This clinical trial update describes multimodal MRI approaches for studying multiple sclerosis and neuromyelitis optica spectrum disorder.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2016-08-04Clinical Trial Update: A Trial to Investigate the Effectiveness of Testosterone Treatment in Men With Multiple Sclerosis [Phase 2]
A Phase 2 trial evaluating testosterone treatment for men with multiple sclerosis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-08-04Clinical Trial Update: Expiratory Muscle Conditioning in Multiple Sclerosis Using Magnetic Stimulation [NA]
The Cleveland Clinic-sponsored clinical trial evaluating expiratory muscle conditioning in multiple sclerosis using magnetic stimulation has…
-
CLINICAL_TRIALS trial_result · 2016-08-01Clinical Trial Update: Consolidation & Interference in Multiple Sclerosis [NA]
The clinical trial update indicates the study on consolidation and interference in Multiple Sclerosis has completed, sponsored by Kessler Fo…
-
CLINICAL_TRIALS trial_result · 2016-07-29Clinical Trial Update: Re-training to Effort (RE) According to the Severity of Multiple Sclerosis: Preliminary Assessments Based on Fatigue and Quality of Life
The document reports preliminary assessments from a completed trial of the Re-training to Effort (RE) program for multiple sclerosis. It exa…
-
CLINICAL_TRIALS trial_result · 2016-07-29Clinical Trial Update: The Effects of Focal Vibration on Spasticity in Multiple Sclerosis Patients [NA]
This clinical trial update discusses the effects of focal vibration on spasticity in people with multiple sclerosis, with the trial status c…
-
CLINICAL_TRIALS withdrawal · 2016-07-20Clinical Trial Update: Mechanisms of Action of Dimethyl Fumarate (Tecfidera) in Relapsing MS [Phase 4]
A Phase 4 trial evaluating the mechanism of action of dimethyl fumarate in relapsing multiple sclerosis has been withdrawn.
-
CLINICAL_TRIALS research · 2016-07-18Clinical Trial Update: Role of Virtual Reality in MS Rehabilitation [NA]
A completed clinical trial evaluating virtual reality in rehabilitation for people with multiple sclerosis.
-
FDA approval · 2016-07-14FDA Approved: PLEGRIDY PEN — Supplemental Application (Biogen Inc.)
The FDA approved Biogen's supplemental application for Plegridy Pen, a pen-style autoinjector for peginterferon beta-1a, expanding its deliv…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Safety and Efficacy of AVP-923 for Pseudobulbar Affect in Multiple Sclerosis Patients [Phase 3]
This clinical trial update covers safety and efficacy data from a Phase 3 study of AVP-923 for pseudobulbar affect in patients with multiple…
-
CLINICAL_TRIALS trial_result · 2016-06-28Clinical Trial Update: Nanotechnology for Detection of Multiple Sclerosis Compared to Autoimmune and Neurological Diseases by Exhaled Samples [NA]
This update reports the completion of a clinical trial evaluating a nanotechnology-based exhaled-sample test to detect multiple sclerosis an…
-
CLINICAL_TRIALS trial_result · 2016-06-28Clinical Trial Update: Observational Study for Assessment of the Effect of Fampyra on the Manual Function of Persons With Multiple Sclerosis
An observational study assessing the effect of dalfampridine (Fampyra) on manual function in people with multiple sclerosis has been complet…
-
CLINICAL_TRIALS trial_result · 2016-06-24Clinical Trial Update: Effect of an Internet-based At-home Physical Training Protocol on Quality of Life, Fatigue, Functional Performance, Aerobic Capacity and Muscle Strength in Multiple Sclerosis Patients [NA]
This update reports the completion of a clinical trial evaluating an at-home internet-based physical training program for people with multip…
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: Efficacy Study of Andrographis Paniculata Purified Standardized Extract (ApE) in Patients With Multiple Sclerosis (MS) [Phase 1, Phase 2]
A clinical trial update reporting a Phase 1/Phase 2 efficacy study of Andrographis Paniculata Purified Standardized Extract (ApE) in relapsi…
-
CLINICAL_TRIALS trial_result · 2016-06-14Clinical Trial Update: Dual Task Cost in the Upper Limb in Persons With Multiple Sclerosis [NA]
This is a completed clinical trial update examining dual task cost in the upper limb for people with multiple sclerosis.
-
CLINICAL_TRIALS research · 2016-06-14Clinical Trial Update: Psychometric Properties Mobility Measures MS [NA]
Completed clinical trial assessing the psychometric properties of mobility measures in people with multiple sclerosis. The study evaluates t…
-
CLINICAL_TRIALS trial_result · 2016-06-14Clinical Trial Update: Fingolimod Real World Experience: the French Grand-Est Cohort
This clinical trial update reports real-world experience with fingolimod in Multiple Sclerosis patients in the Grand-Est region of France. T…
-
CLINICAL_TRIALS trial_result · 2016-06-07Clinical Trial Update: A 12 -Month, Open-label, Multi-center Study to Explore the Health Outcomes of FTY720 [Phase 4]
A 12-month, open-label, multicenter Phase 4 trial evaluating health outcomes of fingolimod (FTY720) in relapsing-remitting multiple sclerosi…
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: Transcutaneous Tibial Nerve Stimulation of Patients With Overactive Bladder (OAB) Syndrome [Phase 2]
A Phase 2 study evaluating transcutaneous tibial nerve stimulation for overactive bladder (including patients with multiple sclerosis) has c…
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: Study to Compare the Clinical and Radiological Efficacy of 625 mg Versus 1250 mg of Oral Methylprednisolone in Patients With Multiple Sclerosis in Relapse [Phase 4]
A Phase 4 study comparing 625 mg versus 1250 mg of oral methylprednisolone for relapse in multiple sclerosis has completed.
-
FDA approval · 2016-06-02FDA Approved: AUBAGIO — Supplemental Application (Genzyme Corporation)
The FDA approved a supplemental application for AUBAGIO (teriflunomide) filed by Genzyme Corporation.